Back to 
BlackRock, Inc.
BlackRock, Inc.
SABS7 quarters
Position history for BlackRock, Inc.'s holdings in SAB BIOTHERAPEUTICS INC
BlackRock, Inc. holds 3.1M shares of SABS (SAB BIOTHERAPEUTICS INC), worth $12M as of 2026-Q2. The position was increased (+917.5% shares). SABS represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$12M
Current Shares
3.1M
Total Value Change
+$11.9M
Total Shares Change
+3M
Quarter-by-Quarter History
Other major holders of SABS: ADAGE CAPITAL PARTNERS GP, L.L.C., RA CAPITAL MANAGEMENT, L.P., BALYASNY ASSET MANAGEMENT L.P.